1-5 of 5
Ye Xiong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

Sonia Singh, Diana Bradford, Somak Chatterjee, Xiaoxue Li, Stephanie L. Aungst, Amy M. Skinner, Claudia P. Miller, Sarah Kim-McOlash, Jeanne Fourie Zirkelbach, Ye Xiong, Youwei Bi, Ying-Hong Wang, Yuching Yang, Jielin Sun, Jeffrey Kraft, Rosane Charlab, Stacy S. Shord, Shenghui Tang, Barbara Scepura, Ilynn Bulatao, Opeyemi Udoka, Haleh Saber, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Martha Donoghue, Nicole Drezner
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (8): 1383–1389.
https://doi.org/10.1158/1078-0432.CCR-24-3439
Published: 14 April 2025
View articletitled, FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma
Open the PDF for FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma in another window
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum

Sonia Singh, Diana Bradford, Xiaoxue Li, Pallavi S. Mishra-Kalyani, Yuan-Li Shen, Lingshan Wang, Hong Zhao, Ye Xiong, Jiang Liu, Rosane Charlab, Jeffrey Kraft, Sachia Khasar, Claudia P. Miller, Donna R. Rivera, Paul G. Kluetz, Richard Pazdur, Julia A. Beaver, Harpreet Singh, Martha Donoghue
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 23–28.
https://doi.org/10.1158/1078-0432.CCR-23-1270
Published: 05 January 2024
View articletitled, FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum
Open the PDF for FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum in another window
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation

Sandra J. Casak, Shan Pradhan, Lola A. Fashoyin-Aje, Yi Ren, Yuan-Li Shen, Yuan Xu, Edwin Chiu Yuen Chow, Ye Xiong, Jeanne Fourie Zirklelbach, Jiang Liu, Rosane Charlab, William F. Pierce, Nataliya Fesenko, Julia A. Beaver, Richard Pazdur, Paul G. Kluetz, Steven J. Lemery
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2733–2737.
https://doi.org/10.1158/1078-0432.CCR-21-4462
Published: 01 July 2022
View articletitled, FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation
Open the PDF for FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation in another window
Journal Articles

The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma

Liang Tang, Ye-Xiong Tan, Bei-Ge Jiang, Yu-Fei Pan, Shuang-Xi Li, Guang-Zhen Yang, Min Wang, Qing Wang, Jian Zhang, Wei-Ping Zhou, Li-Wei Dong, Hong-Yang Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2014–2024.
https://doi.org/10.1158/1078-0432.CCR-12-0349
Published: 15 April 2013
View articletitled, The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma
Open the PDF for The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma

Ye-Xiong Li, Qing-Feng Liu, Hui Fang, Shu-Nan Qi, Hua Wang, Wei-Hu Wang, Yong-Wen Song, Jiade Lu, Jing Jin, Shu-Lian Wang, Yue-Ping Liu, Ning Lu, Xin-Fan Liu, Zi-Hao Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2905–2912.
https://doi.org/10.1158/1078-0432.CCR-08-2914
Published: 15 April 2009
View articletitled, Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma
Open the PDF for Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma in another window
Includes: Supplementary data